<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="147808">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01673087</url>
  </required_header>
  <id_info>
    <org_study_id>1R01MH093486-01A1</org_study_id>
    <nct_id>NCT01673087</nct_id>
  </id_info>
  <brief_title>Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures</brief_title>
  <official_title>Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cortisol is a stress hormone that can be measured in saliva.  This has provided a convenient
      way to evaluate the biological impact of day-to-day stressors that people encounter as they
      go about their lives, since saliva is so easy to collect.  However, the biological meaning
      of saliva cortisol measures has never been carefully examined.  The goal of this study is to
      collect saliva from a large group of people as they go about their every-day lives, to
      measure their cortisol levels, and then study them in the laboratory where Investigators can
      learn more about how their stress response system (which produces cortisol) is really
      functioning.  Investigators can then determine much more precisely what saliva cortisol
      levels really mean in terms of stress system biology.  This will allow investigators to
      obtain much more useful information from the next decade of research on naturalistic stress
      and its biological impact using saliva cortisol measures, helping investigators to
      understand how stress undermines health and how to combat this effect.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>cortisol levels</measure>
    <time_frame>Primarily measuring change from pre-drug baseline to peak occuring about 20 minutes to an hour later</time_frame>
    <safety_issue>No</safety_issue>
    <description>cortisol measured in saliva and in blood.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>corticotropin (ACTH)</measure>
    <time_frame>Primarily measuring change from pre-drug baseline to peak occuring about 10 minutes to an hour later</time_frame>
    <safety_issue>No</safety_issue>
    <description>ACTH will be measured in blood using chemoluminescence detection.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Stress</condition>
  <arm_group>
    <arm_group_label>laboratory HPA probes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will be studied with multiple probes of HPA axis function over the course of one to two months:
Metyrapone, oral, 750 mg, administered twice 3.5 hrs apart; Dexamethasone, oral, 1.5 mg administered once; oral, 0.25 mg administered once; Corticorelin ovine triflutate (CRH), intravenous, 100 mcg, administered once over 30 seconds; Cortrosyn (ACTH), intravenous, 250 mcg, administered once by bolus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metyrapone</intervention_name>
    <description>750 mcg, oral, administered twice, 3.5 hours apart</description>
    <arm_group_label>laboratory HPA probes</arm_group_label>
    <other_name>Metopirone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Administered twice:
1.5 mg, oral, at 11 pm And 0.25 mg, oral, at bedtime at least one week before or after other administration.</description>
    <arm_group_label>laboratory HPA probes</arm_group_label>
    <other_name>Decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cortrosyn</intervention_name>
    <description>250 mcg, IV, bolus, in the afternoon.</description>
    <arm_group_label>laboratory HPA probes</arm_group_label>
    <other_name>Cosyntropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticorelin ovine triflutate</intervention_name>
    <description>100 mcg, IV, over 30 seconds, in the afternoon.</description>
    <arm_group_label>laboratory HPA probes</arm_group_label>
    <other_name>Acthrel</other_name>
    <other_name>Corticotropin-Releasing Hormone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medically healthy volunteers, ages 18 to 50 years

        Exclusion Criteria:

          -  Pregnancy

          -  Irregular menses, medications or drugs that effect HPA axis

          -  Most psychiatric disorders

          -  Medical problems that effect HPA axis or increase risks involved in participation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James L Abelson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hedieh Briggs, MSW</last_name>
    <phone>734-764-5349</phone>
    <email>hedieh@umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin McRobert, MSW</last_name>
    <phone>734-232-0200</phone>
    <email>erinmcro@umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James L Abelson, MD</last_name>
      <phone>734-764-5348</phone>
      <email>jabelson@umich.edu</email>
    </contact>
    <investigator>
      <last_name>James L Abelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>August 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>James Abelson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>stress biology</keyword>
  <keyword>cortisol</keyword>
  <keyword>adrenocorticotropin</keyword>
  <keyword>salivary biomarkers</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
    <mesh_term>Corticotropin-Releasing Hormone</mesh_term>
    <mesh_term>Cosyntropin</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Metyrapone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
